|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.140 NOK | +1.95% |
|
-2.48% | +30.18% |
| 05-27 | Nykode Therapeutics AS Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-27 | Nykode Therapeutics AS, Q1 2026 Earnings Call, May 27, 2026 |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +1.95% | -2.48% | -6.55% | -3.24% | +30.18% | +73.48% | -88.17% | -95.86% | - | 101M | ||
| +3.98% | +5.55% | +18.90% | +27.50% | +15.12% | +76.40% | +136.18% | +214.48% | +6,893.22% | 56.21B | ||
| -3.12% | +5.11% | +21.31% | +16.85% | +33.83% | +71.57% | +94.67% | -27.80% | - | 55.38B | ||
| +3.15% | +7.55% | +8.59% | +6.16% | +1.68% | -10.59% | -10.23% | -56.79% | - | 23.75B | ||
| +2.14% | +4.54% | +5.29% | -32.76% | -37.25% | +11.17% | +426.34% | +283.21% | +967.60% | 23.19B | ||
| +3.64% | +10.54% | +3.58% | +2.87% | +14.06% | +39.81% | -4.50% | -74.80% | - | 18.14B | ||
| +4.11% | +8.89% | +21.33% | +6.99% | -7.55% | +44.60% | -27.73% | -28.01% | +52.36% | 16.84B | ||
| +2.57% | +20.26% | +45.01% | +119.69% | +196.81% | +181.98% | +355.99% | +1,677.35% | +662.64% | 15.86B | ||
| +1.80% | +3.21% | +13.19% | +25.21% | +25.35% | +24.02% | +187.19% | +200.88% | +582.48% | 13.56B | ||
| +7.20% | +10.70% | +7.40% | -5.92% | +19.22% | +42.91% | - | - | - | 12.97B | ||
| +2.10% | +2.04% | +15.77% | -4.14% | -9.97% | +74.67% | +132.20% | +429.57% | - | 11.86B | ||
| +2.30% | +7.95% | +23.00% | +30.71% | +37.27% | +153.84% | +161.45% | +323.19% | +789.09% | 11.58B | ||
| +1.16% | +3.09% | +15.39% | +33.90% | +23.09% | +383.55% | +132.16% | +29.45% | +1,421.79% | 11.33B | ||
| +4.87% | +6.42% | +1.55% | -22.14% | -13.72% | -33.29% | +523.55% | +94.71% | +91.97% | 11.16B | ||
| +7.67% | +8.34% | -18.21% | -31.90% | -16.11% | +3.10% | +168.18% | +51.32% | - | 10.34B | ||
| +0.02% | +0.09% | +35.35% | +17.28% | +22.92% | +53.60% | +195.94% | - | - | 9.76B | ||
| -0.43% | +17.84% | +26.97% | +25.75% | +363.64% | +247.73% | +235.04% | -34.38% | - | 9.64B | ||
| +7.74% | +16.18% | +2.10% | -27.49% | +11.18% | +47.02% | +133.72% | -32.39% | - | 9.21B | ||
| +2.66% | +7.28% | +21.47% | -1.35% | +24.82% | +73.10% | +17.03% | +152.70% | - | 8.1B | ||
| -2.64% | -2.75% | +24.69% | +81.24% | +163.23% | +456.35% | +652.32% | -50.93% | -24.69% | 7.72B | ||
| Average | +2.65% | +5.38% | +14.31% | +13.26% | +44.89% | +100.75% | +180.07% | +169.77% | +1,270.72% | 16.84B | |
| Weighted average by Cap. | +2.19% | +5.61% | +16.12% | +15.12% | +33.53% | +82.11% | +164.54% | +172.60% | +2,718.84% |
- Stock Market
- Stocks
- VACC Stock
- Sector Nykode Therapeutics
Select your edition
All financial news and data tailored to specific country editions
















